CHICAGO--(BUSINESS WIRE)--Clinically viable model-based iterative reconstruction is now a reality with the launch of Toshiba America Medical Systems, Inc.’s Forward projected model-based Iterative Reconstruction SoluTion (FIRST) (pending 510(k) clearance). FIRST improves image quality with significant noise reduction while reducing radiation dose and drastically cuts the time needed for model-based CT image reconstruction, helping providers make critical diagnoses and treatment decisions more effectively.
Available for the AquilionTM ONE Family of CT systems, FIRST improves high-contrast spatial resolution and helps to make exams safer for patients by providing reduction in dose, meaning customers don’t need to choose between safety and high quality images.
“With FIRST, we saw a way to take industry-changing technology beyond the research setting and help our clinical partners use it to benefit their patients,” said Satrajit Misra, vice president, Marketing, Toshiba. “As we strive to provide best-in-class technology, FIRST is an integrated, fast and easy-to-use clinical solution that makes imaging safer while providing the very best in image quality.”
Toshiba will introduce FIRST at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, November 29 - December 4, 2015 (Booth #7336, North Hall).
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit Toshiba’s website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.
Toshiba Corporation, a Fortune Global 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future”, Toshiba promotes global operations and is contributing to the realization of a world where generations to come can live better lives.
Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 580 consolidated companies employing 199,000 people worldwide, with annual sales surpassing 6.6 trillion yen (US$55 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.
Aquilion ONE is a trademark of Toshiba Medical Systems Corporation.